Searching over 5,500,000 cases.


searching
Buy This Entire Record For $7.95

Official citation and/or docket number and footnotes (if any) for this case available with purchase.

Learn more about what you receive with purchase of this case.

L.P.P.R., Inc. and Lehigh Press Pharmaceutical v. Keller Crescent Corporation

IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF PENNSYLVANIA


August 31, 2012

L.P.P.R., INC. AND LEHIGH PRESS PHARMACEUTICAL PRODUCTS, INC. PLAINTIFFS,
v.
KELLER CRESCENT CORPORATION AND CLONDALKIN GROUP, INC. DEFENDANTS.

The opinion of the court was delivered by: Michael M. Baylson, U.S.D.J.

ORDER RE: MOTION TO MOLD AMENDED JUDGMENT TO INCLUDE INTEREST

AND NOW, this 31st day of August, 2012, upon consideration of Plaintiffs' Request to Mold the Amended Judgment to Include Interest (ECF No. 141), and statement by Defendants' counsel that Defendants would not file a response to the motion and that the motion could be granted as unopposed, it is hereby ORDERED as follows: (1) Plaintiffs' Motion (ECF No. 141) is GRANTED; (2) JUDGMENT IS ENTERED in favor of Plaintiffs L.P.P.R., Inc. and Lehigh Press Pharmaceutical Products, Inc., and against Keller Crescent Corporation and Clondalkin Group, Inc., jointly and severally, in the amount of $317,449.88 (i.e. $286,123.30, plus $31,326.58 in prejudgment interest, calculated at 5.75% simple interest for the 695 days between September 19, 2010 and August 14, 2012), plus post-judgment interest until the judgment is paid.

BY THE COURT:

Michael M. Baylson

20120831

© 1992-2012 VersusLaw Inc.



Buy This Entire Record For $7.95

Official citation and/or docket number and footnotes (if any) for this case available with purchase.

Learn more about what you receive with purchase of this case.